2 withdrawn. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Cannabis: new trials by email Literature Review of Cannabis trials Research Report on Cannabis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease Cannabidiol, Placebo oral capsule - Crohn Disease, Inflammatory Bowel Diseases | Phase 2 / Phase 3 | Withdrawn | University of Illinois at Chicago | 2018-07-01 | 2020-03-25 | |
| The Effect of Cannabis in Pancreatic Cancer THC and CBD Mixture - Neoplasms Pancreatic, Cachexia; Cancer | Phase 2 | Withdrawn | Jens Rikardt Andersen | 2017-10-06 | 2023-12-18 |
Marijuana Abuse (2) · Anorexia (1) · Cachexia (1) · Crohn Disease (1) · Inflammatory Bowel Diseases (1) · Neoplasms (1) · Pancreatic Neoplasms (1)
Chemically-Induced Disorders (2) · Digestive System Diseases (2) · Mental Disorders (2) · Substance-Related Disorders (2) · Body Weight (1) · Body Weight Changes (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Neoplasms by Site (1) · Pancreatic Diseases (1) · Pathological Conditions, Signs and Symptoms (1)
Cannabidiol (1) · Cannabinoids (1) · nabiximols (1)
Jens Rikardt Andersen (1) · University of Illinois at Chicago (1)
Denmark (1)
Jens Rikardt Andersen, MD, MPA (1)
PMID 12648025, PMID 16317825, PMID 17566383, PMID 18728826, PMID 19587829, PMID 19883531, PMID 19896326, PMID 20076976, PMID 22076835, PMID 23141881, PMID 26883879, PMID 27403414